发明公开
EP1366167A2 MATERIEL BIOLOGIQUE POUR LA PREPARATION DE COMPOSITIONS PHARMACEUTIQUES DESTINEES AU TRAITEMENT DE MAMMIFERES 审中-公开
生物材料药物组合物的哺乳动物的治疗PRODUCTION

  • 专利标题: MATERIEL BIOLOGIQUE POUR LA PREPARATION DE COMPOSITIONS PHARMACEUTIQUES DESTINEES AU TRAITEMENT DE MAMMIFERES
  • 专利标题(英): Biological organism for preparing pharmaceutical compositions for treating mammals
  • 专利标题(中): 生物材料药物组合物的哺乳动物的治疗PRODUCTION
  • 申请号: EP02701327.5
    申请日: 2002-01-28
  • 公开(公告)号: EP1366167A2
    公开(公告)日: 2003-12-03
  • 发明人: PAUL, StéphaneREGULIER, Etienne
  • 申请人: TRANSGENE S.A.
  • 申请人地址: 11, rue de Molsheim 67000 Strasbourg FR
  • 专利权人: TRANSGENE S.A.
  • 当前专利权人: TRANSGENE S.A.
  • 当前专利权人地址: 11, rue de Molsheim 67000 Strasbourg FR
  • 代理机构: Ahner, Francis
  • 优先权: EP01440017 20010126
  • 国际公布: WO02059291 20020801
  • 主分类号: C12N15/13
  • IPC分类号: C12N15/13
MATERIEL BIOLOGIQUE POUR LA PREPARATION DE COMPOSITIONS PHARMACEUTIQUES DESTINEES AU TRAITEMENT DE MAMMIFERES
摘要:
The invention concerns a biological organism comprising at least: (i) a nucleic acid coding for all or part of an antibody, said antibody being expressed at the surface of a host cell and capable of being fixed to a polypeptide present at the surface of a cytotoxic effector cell or of a T-helper lymphocyte and involved in the process of activating such a cell and (ii) a nucleic acid coding for all or part of a polypeptide involved in the stimulation of an immune response or in attraction to the site of expression and activation of cytotoxic effector cells or of T-helper lymphocytes, said polypeptide being selected among chemokines and co-stimulation molecules. The invention also concerns a host cell and a pharmaceutical composition containing said biological organism and their therapeutic or prophylactic uses.
信息查询
0/0